Charlene Hazen
About Charlene Hazen
Charlene Hazen is the Manager of Quality Assurance Compliance Cell Therapy at Bristol Myers Squibb, with over thirty years of experience in the pharmaceutical industry.
Title: Manager, Quality Assurance Compliance Cell Therapy
Charlene Hazen currently holds the role of Manager, Quality Assurance Compliance Cell Therapy at Bristol Myers Squibb in Warren, NJ. In this capacity, she oversees quality assurance processes and ensures compliance with regulatory standards. Her responsibilities extend to conducting audits, fostering continuous process improvements, and implementing corrective actions where necessary.
Work Experience in Pharmaceutical Quality Assurance
With thirty years of experience in Quality units within the pharmaceutical industry, Charlene Hazen has held various key roles in prominent companies. Her positions have included roles at Novartis, Dendreon, Pfizer (formerly Wyeth), Wyeth Pharmaceuticals, IVAX, IBAH, and Bayer (formerly Sterling Health). She has extensive experience in conducting audits, coordinating investigations, authoring procedures, and implementing process improvements and corrective actions.
Previous Role at Wallace Laboratories
Charlene Hazen began her career as a Chemist at Wallace Laboratories, where she worked from 1987 to 1992. During her five years in this role, she gained foundational experience in laboratory procedures and practices, which contributed to her extensive knowledge in the field of chemistry and quality assurance.
Education and Expertise in Chemistry from Rutgers University
Charlene Hazen studied at Rutgers University, achieving a B.A. in Chemistry from 1980 to 1984. Her education provided her with a solid foundation in chemical sciences, which she has applied throughout her extensive career in the pharmaceutical industry.
Background in Supervisory Roles in the Pharmaceutical Industry
Charlene Hazen's career includes supervisory positions such as Supervisor of QA at Dendreon and Training Team Leader at Wyeth Pharmaceuticals. She has organized and conducted Consent Decree related activities and has proven her capability in managing teams and ensuring regulatory compliance.